Clinical Trial Update: Losartan + Sunitinib in Treatment of Osteosarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the combination of Losartan and Sunitinib for osteosarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Losartan (losartan)
• Sutent (sunitinib)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Osteosarcoma | Phase 1 | Status: RECRUITING